Merck
所有图片(3)

V8138

Sigma-Aldrich

万古霉素 盐酸盐 来源于东方链霉菌

meets USP testing specifications

Empirical Formula (Hill Notation):
C66H75Cl2N9O24 · HCl
CAS号:
分子量:
1485.71
Beilstein:
3704657
PubChem化学物质编号:

质量水平

200

生物来源

Streptomyces orientalis

Agency

USP/NF
meets USP testing specifications

测定

≥900 μg/mg (as vancomycin base)

储存条件

(Keep container tightly closed in a dry and well-ventilated place.)

抗生素抗菌谱

Gram-positive bacteria

application(s)

pharmaceutical (small molecule)

作用机制

cell wall synthesis | interferes

储存温度

2-8°C

SMILES string

Cl[H].CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]2C[C@](C)(N)[C@@H](O)[C@@H](C)O2.CN[C@H](CC(C)C)C(=O)NC3[C@H](O)c4ccc(Oc5cc6Oc7ccc(cc7Cl)[C@@H](O)[C@H]8NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CC(N)=O)NC3=O)c(c5)c6)c9ccc(O)c(c9)-c%10c(O)cc(O)cc%10[C@@H](NC8=O)C(O)=O)c(Cl)c4

正在寻找类似产品? Visit 产品对比指南

相关类别

一般描述

Chemical structure: glycopeptide

包装

250 mg in glass bottle
1, 5 g in glass bottle

生化/生理作用

糖肽抗生素
作用模式:用于通过抑制NAM/NAG-肽的末端D-丙氨酰-D-丙氨酸部分的插入在肽聚糖生物合成水平阻断细菌细胞壁生物合成。
抗菌谱:革兰氏阳性菌

其他说明

Keep container tightly closed in a dry and well-ventilated place.

象形图

Health hazard

警示用语:

Danger

危险声明

危险分类

Resp. Sens. 1 - Skin Sens. 1

储存分类代码

11 - Combustible Solids

WGK

WGK 2

闪点(F)

Not applicable

闪点(C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

分析证书

请输入批号搜索分析证书(COA)。

原产地证书 (CofO)

请输入批号搜索原产地证书(COO)。

更多文件

Quotes and Ordering

Jacqueline C Y Lai et al.
Antimicrobial agents and chemotherapy, 64(3) (2019-12-11)
Infection is correlated with increased risk of neurodevelopmental sequelae in preterm infants. In modeling neonatal brain injury, Toll-like receptor agonists have often been used to mimic infections and induce inflammation. Using the most common cause of bacteremia in preterm infants
Celine Vidaillac et al.
The Journal of infectious diseases, 208(1), 67-74 (2013-03-30)
We used 2 in vitro experimental systems to compare phenotypic and genotypic changes that accompany selection of mutants of methicillin-resistant Staphylococcus aureus (MRSA) strain JH1 with low-level vancomycin resistance similar to the type found in vancomycin-intermediate S. aureus (VISA). The
Oliver A Cornely et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(19), 2493-2499 (2013-05-30)
Patients with cancer are at increased risk for Clostridium difficile-associated diarrhea (CDAD). Little is known about treatment response. Two double-blind trials randomly allocated 1,105 patients with CDAD to fidaxomicin or vancomycin treatment (modified intent-to-treat [mITT]), and 183 of these had
David W Eyre et al.
The Journal of infectious diseases, 209(9), 1446-1451 (2013-11-13)
Whole-genome sequencing was used to determine whether the reductions in recurrence of Clostridium difficile infection observed with fidaxomicin in pivotal phase 3 trials occurred by preventing relapse of the same infection, by preventing reinfection with a new strain, or by
Wessam Abdelhady et al.
The Journal of infectious diseases, 209(8), 1231-1240 (2014-01-10)
Staphylococcus aureus is the most common cause of endovascular infections. The staphylococcal accessory regulator A locus (sarA) is a major virulence determinant that may potentially impact methicillin-resistant S. aureus (MRSA) persistence in such infections via its influence on biofilm formation.

相关内容

Inhibition of Cell Wall Biosynthesis by Antibiotics

Inhibition of Cell Wall Biosynthesis by Antibiotics

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门